Lisocabtagene Maraleucel,ibrutinib,venetoclax
Bms,Roche,Abbvie
['cll', 'pivotal trial']
car-t in cll! serves an unmet clinical need in btk/ven refractory patients. impressive outcomes presented at #asco23. excited to be a part of this pivotal trial now published in the lancet! 